These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 19585394

  • 1. Aripiprazole as an adjunct to clozapine therapy in adolescents with early-onset schizophrenia: a retrospective chart review.
    Bachmann CJ, Lehr D, Theisen FM, Preiss M.
    Pharmacopsychiatry; 2009 Jul; 42(4):153-7. PubMed ID: 19585394
    [Abstract] [Full Text] [Related]

  • 2. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A, CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group.
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [Abstract] [Full Text] [Related]

  • 3. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
    De Risio A, Pancheri A, Simonetti G, Giannarelli D, Stefanutto L, Gentile B.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1112-6. PubMed ID: 21447367
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
    Cipriani A, Accordini S, Nosè M, Purgato M, Girlanda F, Tansella M, Barbui C.
    J Clin Psychopharmacol; 2013 Aug 01; 33(4):533-7. PubMed ID: 23775051
    [Abstract] [Full Text] [Related]

  • 5. Is clozapine-aripiprazole combination a useful regime in the management of treatment-resistant schizophrenia?
    Karunakaran K, Tungaraza TE, Harborne GC.
    J Psychopharmacol; 2007 Jun 01; 21(4):453-6. PubMed ID: 17050662
    [Abstract] [Full Text] [Related]

  • 6. Clozapine augmented with aripiprazole in 5 patients with schizophrenia.
    Abu-Tair F, Kopitz J, Bergemann N.
    J Clin Psychopharmacol; 2006 Dec 01; 26(6):669-71. PubMed ID: 17110831
    [No Abstract] [Full Text] [Related]

  • 7. Favourable results in treatment-resistant schizophrenic patients under combination of aripiprazole with clozapine.
    Mossaheb N, Spindelegger C, Asenbaum S, Fischer P, Barnas C.
    World J Biol Psychiatry; 2010 Mar 01; 11(2 Pt 2):502-5. PubMed ID: 20218805
    [Abstract] [Full Text] [Related]

  • 8. Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: An open-label pilot study.
    Mitsonis CI, Dimopoulos NP, Mitropoulos PA, Kararizou EG, Katsa AN, Tsakiris FE, Katsanou MN.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):373-7. PubMed ID: 17092620
    [Abstract] [Full Text] [Related]

  • 9. Who responds to aripiprazole in clinical practice? An observational study of combination versus monotherapy.
    Shajahan P, Macrae A, Bashir M, Taylor M.
    J Psychopharmacol; 2008 Sep 30; 22(7):778-83. PubMed ID: 18308790
    [Abstract] [Full Text] [Related]

  • 10. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
    Wolf J, Janssen F, Lublin H, Salokangas RK, Allain H, Smeraldi E, Bernardo M, Millar H, Pans M, Adelbrecht C, Laughton J, Werner C, Maier W.
    Curr Med Res Opin; 2007 Oct 30; 23(10):2313-23. PubMed ID: 17706003
    [Abstract] [Full Text] [Related]

  • 11. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY, Ham BJ, Kang RH, Paik JW, Hahn SW, Lee MS, Lee MS.
    Psychiatry Clin Neurosci; 2010 Feb 30; 64(1):38-43. PubMed ID: 20416024
    [Abstract] [Full Text] [Related]

  • 12. Treatment of psychotic disorders with aripiprazole in the emergency psychiatric setting.
    Raja M, Azzoni A.
    Psychiatr Danub; 2008 Sep 30; 20(3):323-8. PubMed ID: 18827757
    [Abstract] [Full Text] [Related]

  • 13. Clozapine augmentation with aripiprazole for negative symptoms.
    Clarke LA, Lindenmayer JP, Kaushik S.
    J Clin Psychiatry; 2006 Apr 30; 67(4):675-6. PubMed ID: 16669737
    [No Abstract] [Full Text] [Related]

  • 14. Benefits of combining aripiprazole to clozapine: three case reports.
    Rocha FL, Hara C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1167-9. PubMed ID: 16647796
    [Abstract] [Full Text] [Related]

  • 15. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML, Shen WW, Chen CH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec 12; 32(8):1978-81. PubMed ID: 18848860
    [Abstract] [Full Text] [Related]

  • 16. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY, Lee CI, Chiu NY, Kahn DA.
    J Psychiatr Pract; 2009 May 12; 15(3):221-6. PubMed ID: 19461396
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
    Zink M, Kuwilsky A, Krumm B, Dressing H.
    J Psychopharmacol; 2009 May 12; 23(3):305-14. PubMed ID: 18562423
    [Abstract] [Full Text] [Related]

  • 18. Effect of aripiprazole augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study.
    Muscatello MR, Bruno A, Pandolfo G, Micò U, Scimeca G, Di Nardo F, Santoro V, Spina E, Zoccali RA.
    Schizophr Res; 2011 Apr 12; 127(1-3):93-9. PubMed ID: 21262565
    [Abstract] [Full Text] [Related]

  • 19. Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study.
    Christensen AF, Poulsen J, Nielsen CT, Bork B, Christensen A, Christensen M.
    Acta Psychiatr Scand; 2006 Feb 12; 113(2):148-53. PubMed ID: 16423167
    [Abstract] [Full Text] [Related]

  • 20. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
    Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, Schirmbeck F, Zink M.
    Clin Neuropharmacol; 2009 Feb 12; 32(4):227-9. PubMed ID: 19644230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.